In this piece, we’ll take a look at the 10 stocks that will change the world.
If we were to try and summarize one of the biggest ways how to make money on the stock market, it’d include buying stocks of firms that have changed the world. The biggest and most valuable companies of today didn’t start that way, and those who had a chance to invest in them decades back are considerably well off and some are even among the richest people in the world.
In fact, the two biggest technologies that have changed the world since the 1970s are personal computing and the Internet. Within these, the former is older and started through the launch of products such as Windows and the Mac. The two companies that make these products are up by 405,920% and 166,238% on the stock market since their shares were listed. So, if you, or anyone you know, had bought $1,000 of shares back then, your investment would be worth $4 million or $1.7 million today.
Along with personal computing, the Internet is the second world changing technology that has not only reformed the way in which businesses operate and regular people live their lives but also left a slew of billionaires in its wake. Starting from the dotcom era of the 1990s, the few companies that did survive the ‘pop’ are among the largest and most valuable in the world today. These have managed to use the power of the Internet to change the way people shop and access information. The former, founded by Jeff Bezos, whose latest net worth is estimated to sit at $190 billion, is up 185,389% since its stock started trading.
A $1,000 investment back then would be worth $1.9 million. Similarly, the world’s largest search engine company and the world’s biggest social media firm, are up by 5,939% and 1,254% since their stock started trading in the 2000s. It’s a testament to the power of world changing technologies to drive stock prices that these quad digit percentage returns appear to be ‘meager’ when compared to the six digit returns of the world changing stocks that have been trading since the 1970s and the 1990s.
But what about 2024? After all, while these disruptive stocks have made their mark on Wall Street history, it is highly unlikely that they will yield similar returns in the future. Well, one disruptive technology that has caught the world by storm is artificial intelligence. Spurred by the public launch of the chatbot ChatGPT, AI’s proponents swear that it will transform the world just like the Internet did. This transformation is being spearheaded by big tech, as the largest technology companies in the world fork out billions of dollars in AI spending.
Data shows that during the first half of 2024, the four biggest AI players spent a whopping $106 billion in spending as part of a game theory-esque roulette that Mark Zuckerberg described as risking “building capacity before it is needed, rather than too late.” As for the future, analysts expect that AI spending over the next five years could touch a whopping $1 trillion. This spending has also driven the shares of the world’s pre eminent AI GPU maker (and the youngest game changing stock) to rise by 261,775% since they started trading.
Looking at these gains makes it even more important that we try to wager a guess at what future industries can change the world. One way to somewhat simplify our research is to look at what investment newsletters are saying. The writers of these newsletters are often on the hunt for high growth sectors since correctly identifying them leads to a boost of credibility that drives subscriptions and eventually leads to revenue. On this front, we looked at some such industries as part of our coverage of 10 Stocks That Will Skyrocket.
Within these industries, two that stand out are quantum computing and nuclear energy. For those out of the loop, quantum computing is an expansion of current computing as it significantly increases the data that a computer can compute. However, quantum computing stocks are laggards in the stock market. We covered top hedge fund quantum computing stock picks during our coverage of 12 Best Quantum Computing Stocks To Invest In. Out of these 12 stocks, 10 either have quantum computing returns baked into their stock price or are too important in the industry to ignore. Analyzing their year to date performance reveals that out of these ten quantum computing stocks, four are in the green and this drops to three if we focus only on pureplay quantum computing stocks. These three stocks rank 5th, 7th, and 12th on our list, and they are up by 2.7% to 129.75%, year to date.
For nuclear energy, let’s look at the stocks that are part of the list of the 12 Best Nuclear Energy Stocks To Buy Today. In this list, roughly seven nuclear energy stocks have considerable exposure to power generation. Their one year share price appreciation ranges between 79.8% to 11.38%, and the top three performing stocks are ranked 3rd, 5th, and 12th. As a refresher, nuclear energy is popular these days because of its potential to provide clean energy to AI data centers.
Finally, another sector that might change the world is robotics. Some Wall Street analysts are gushing over the sector as they believe that humanoid robots in particular can unlock a $30 trillion opportunity. This is on the back of these robots being able to perform jobs that humans are unwilling or unsuited for, and even Elon Musk is bullish on them as he believes that his car company could benefit from this unstoppable demand and become worth $25 trillion as a result. For more details, you can check out $30 Trillion Opportunity: 15 Best Humanoid Robot Stocks to Buy According to Morgan Stanley.
So, with these details in mind, let’s take a look at the stocks that can change the world.
A high-tech robotic drone, showcasing the companys advancements in unmanned aerial systems.
Our Methodology
To make our list of the stocks that can change the world, we started with our coverage of 10 Stocks That Will Change the Future, analyzed their performance, and fine tuned the list to align with today’s hottest industries. Then, we scanned media reports for sectors such as AI, self driving, gene editing, weight loss drugs, and robotics. From these reports, a stock was chosen if it was mentioned in three or more reports. This yielded a final list of five new stocks.
For these stocks, we have also mentioned the number of hedge fund investors. Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 275% since May 2014, beating its benchmark by 150 percentage points. (see more details here).
14. InMode Ltd. (NASDAQ:INMD)
Number of Hedge Fund Holders In Q1 2024: 20
InMode Ltd. (NASDAQ:INMD) is an Israeli beauty company that deals with procedures such as liposuction and skin tightening. Over the past twelve months, its shares have lost almost 62% of their value. Its stock first fell in October last year, after the firm cut its full year guidance to $505 million compared to an earlier $535 million. The shares continued their downward spiral in December 2023 when InMode Ltd. (NASDAQ:INMD) further slashed the guidance to a $490 million midpoint. The dropping returns, which suggest a lower market for the firm’s products mean that InMode Ltd. (NASDAQ:INMD) is no longer a stock that will change the world. As a result, we have eliminated it from our coverage. This doesn’t mean that the firm doesn’t have a competitive advantage though, since InMode Ltd. (NASDAQ:INMD)’s radio frequency liposuction and other procedures offer considerable safety advantages over surgical and other alternatives.
13. SenseTime Group Inc. (OTC:SNTMF)
Number of Hedge Fund Holders In Q1 2024: N/A
SenseTime Group Inc. (OTC:SNTMF) is a diversified Chinese company that offers software products for industrial applications, smart cities, educational systems, automobiles, and other applications. Its shares have lost 27% over the past year, and since it’s a penny stock, the shares have seen little action since then at least on the OTC markets. SenseTime Group Inc. (OTC:SNTMF)’s been having a fiery year on the markets though, with things coming to a head in late November 2023 when a short seller alleged that the firm had inflated its revenue to deceive investors. Things took another strange turn when roughly three weeks after, SenseTime Group Inc. (OTC:SNTMF)’s founder passed away; an event that shocked investors. April 2024 was a good month for the stock since the shares surged by 2024 in Hong Kong after SenseTime Group Inc. (OTC:SNTMF) announced a new AI model.
12. Medtronic plc (NYSE:MDT)
Number of Hedge Fund Holders In Q1 2024: 54
Medtronic plc (NYSE:MDT) is a medical devices manufacturer based in Ireland. The shares are down by a modest 2.3% over the past year, as they are helped by the fact that Medtronic plc (NYSE:MDT) is one of the biggest medical devices companies in the world. This offers the firm stability in the face of any headwinds. However, the stock is unlikely to change the world since it does not operate in any of today’s hottest industries. In fact, a portion of its weak share price performance is reflected by investor worries on the demand for Medtronic plc (NYSE:MDT)’s products in the wake of GLP-1 weight loss drugs becoming popular. The market is worried that a healthier population with a low incidence of diabetes and other diseases could lower the demand for Medtronic plc (NYSE:MDT)’s products. The firm has a fortress balance sheet though, with $8 billion in cash on hand.
11. GE HealthCare Technologies Inc. (NASDAQ:GEHC)
Number of Hedge Fund Holders In Q1 2024: 56
GE HealthCare Technologies Inc. (NASDAQ:GEHC) is another medical devices company that sells products such as x ray machines, CT machines, ultrasound products, MR machines, and others. This means that while the firm has a sizeable and stable market at its disposal and benefits from recurring revenue as well, the nature of its products and industry leaves little room for disruption. Simply benefiting from AI does not mean that a firm can change the world, so even though GE HealthCare Technologies Inc. (NASDAQ:GEHC)’s machines can incorporate AI to improve diagnostic outcomes, they can face competition from rivals in the space too. The shares tanked by 14% in April after GE HealthCare Technologies Inc. (NASDAQ:GEHC)’s first quarter earnings when revenue of $4.6 billion missed analyst estimates of $4.8 billion.
10. Rockwell Automation Inc. (NYSE:ROK)
Number of Hedge Fund Holders In Q1 2024: 39
Rockwell Automation Inc. (NYSE:ROK) is a sizeable American industrial machinery company with some exposure to robotics. However, it isn’t part of Morgan Stanley’s Humanoid 66 list of firms that benefit from humanoid robots, and the stock is also down by 14% over the past twelve months. As part of our research for this piece, out of the multiple media reports we analyzed for the top robotics stocks, Rockwell Automation Inc. (NYSE:ROK) was present in only one – the lowest for all the robotics stocks in last year’s list. Rockwell Automation Inc. (NYSE:ROK)’s stock tanked by ~18% in January 2024 when its EPS and revenue of $2.04 and $2 billion missed analyst estimates of $2.64 and $2.1 billion, respectively. The shares were in more trouble in August after the firm continued to struggle and its third quarter profit slipped because of supply chain issues.
9. Zebra Technologies Corporation (NASDAQ:ZBRA)
Number of Hedge Fund Holders In Q1 2024: 31
Zebra Technologies Corporation (NASDAQ:ZBRA) is the second stock on our updated list. It is featured in all media reports as part of our coverage, and the firm provides products such as machine vision scanners and robotic automation software. Zebra Technologies Corporation (NASDAQ:ZBRA)’s product portfolio exposes it to the rapidly growing warehouse robotics industry which seeks to improve warehouse and logistics efficiency. The stock has gained 21% over the past twelve months. Zebra Technologies Corporation (NASDAQ:ZBRA) offers a diverse set of supply chain optimization products which range from track and trace products to mobile products for store sales associates. However, since the firm is exposed to the eCommerce industry, its revenue struggles during slow economic growth.
Zebra Technologies Corporation (NASDAQ:ZBRA)’s management shared details for one of its hottest products, mobile computing, during the Q2 2024 earnings call:
“Additionally, we are able to displace consumer cell phones at a European retailer with our mobile computers and Zebra’s Identity Guardian solution. It provides multifactor authentication for a shared device environment that brings security, productivity, and convenience to the front line. It is also notable that mobile computing contributed to double-digit sales growth in healthcare. Over the past year, our teams have been successfully selling the benefits of our solutions and clinical mobility that empower caregivers while delivering lower total cost of ownership for hospital systems.
We have been displacing consumer cell phones with our devices and there continues to be a long runway of opportunity for equipping more clinicians with mobile computers. In closing, we expect to see broad-based growth in the second half as we cycle much easier comparisons and benefit from momentum beyond retail. We maintain strong conviction in our long-term opportunity for Zebra as we elevate our strategic role with our customers through our innovative portfolio of solutions.”
8. Beam Therapeutics Inc. (NASDAQ:BEAM)
Number of Hedge Fund Holders In Q1 2024: 23
Beam Therapeutics Inc. (NASDAQ:BEAM) is a biotechnology company that develops treatments for thalassemia, sickle cell disease, and other ailments. It is one of the most consequential biotechnology stocks as of late, as evidenced by its gene editing platform that works along with industry leading CRISPR slicing. This has allowed Beam Therapeutics Inc. (NASDAQ:BEAM) to target genetic diseases, which have long been thought of as having no cure. This leaves a wide market open for exploitation, and Beam Therapeutics Inc. (NASDAQ:BEAM) is already dosing patients for its historic attempt at helping those who suffer from sickle cell disease. On the flip side, the risks are equally higher, as any negatives on the regulatory or safety front could bode into disaster for the firm. Beam Therapeutics Inc. (NASDAQ:BEAM) also has hefty cash reserves of $1.1 billion which should help it try to crack the nut of genetic diseases for quite some time.
7. Intellia Therapeutics, Inc. (NASDAQ:NTLA)
Number of Hedge Fund Holders In Q1 2024: 29
Intellia Therapeutics, Inc. (NASDAQ:NTLA) is another gene editing company. The firm develops treatments for hemophilia, lung disease, angioedema, and other ailments. Intellia Therapeutics, Inc. (NASDAQ:NTLA) is currently making rapid progress in its angioedema treatment, and the firm is slated to start an all important phase three clinical trial in the current half of this year. It is also testing its cardiomyopathy treatment, which creates additional potential tailwinds for the stock. Intellia Therapeutics, Inc. (NASDAQ:NTLA)’s angioedema treatment trial also expands the target base to women of childbearing age, which means that the market for the drug will be larger than other products from rivals. Gene editing is a technology that can change the world, and Intellia Therapeutics, Inc. (NASDAQ:NTLA) might benefit from it if it manages to successfully execute its product pipeline and keep other troubles at bay.
Intellia Therapeutics, Inc. (NASDAQ:NTLA)’s management shared details for its treatments during the Q2 2024 earnings call when it shared:
“A single 25- or 50-milligram dose of NTLA-2002 led to deep reductions in attacks for patients with HAE. No new safety findings were observed. We have now selected the 50-milligram dose to advance into the global Phase III trial because we saw greater calotrene reduction and, importantly, a higher number of patients who achieved complete elimination of attacks compared to the 25-milligram dose cohort, which is consistent with the prior Phase I results. In addition to the positive results, we recently completed a successful end of Phase II meeting with the FDA. We believe we have completed addressing their questions and have a clear understanding of the path forward.
We are on track to begin the Phase III trial in the second half of this year and, if positive, plan to submit the BLA for NTLA-2002 in 2026. We anticipate that NTLA-2002 will be the first in vivo gene-editing therapy to come to market and, most importantly, we strongly believe it will reset the standard of care for HAE. Switching now to NTLA-2001 for the treatment of ATTR amyloidosis, the drug now has a new name, Nexiguran Ziclumeran, or NEX-Z for short. Recent competitor data confirmed our longstanding hypothesis that TTR reduction leads to a clinically meaningful improvement in patients with cardiomyopathy. This is an important advancement in the field’s understanding of the disease, and this result further increases our confidence that NEX-Z could lead to even better clinical outcomes for patients.”
6. Amgen Inc. (NASDAQ:AMGN)
Number of Hedge Fund Holders In Q1 2024: 63
Amgen Inc. (NASDAQ:AMGN) is one of the largest healthcare companies in the world which is headquartered in Thousand Oaks, California. Its scale, as evidenced by $97 billion in total assets and $10.9 billion in cash means that Amgen Inc. (NASDAQ:AMGN) has sufficient resources to target the hot weight loss drugs market. This potential was also at the heart of a 12% share price boost in May, when Amgen Inc. (NASDAQ:AMGN)’s executives shared their plans for weight loss products. They revealed that the drug had demonstrated promising initial phase two outcomes, and the complete data that should be available at the end of 2024 should most likely lead to a phase three trial. Amgen Inc. (NASDAQ:AMGN)’s drug, MariTide, appears quite promising on the surface as it promises to reduce dosage. However, the industry is quite proliferated with competing products, and any final product from Amgen Inc. (NASDAQ:AMGN) is years away.
Here’s what Amgen Inc. (NASDAQ:AMGN)’s management had to say about the drug during its latest earnings call:
“Umer, as you know, this medicine coming out of Phase I showed a quite remarkable impact on obesity with a dramatic reduction in BMI, actually proved quite durable after just three doses, MariTide in that Phase I study, we saw persistent weight loss really out 150 days or more at some doses. The Phase II study is a much larger concern. This is a 592 patient study. It has 11 arms, it has monthly or as Murdo said, even less frequent dosing. As a part two that allows us to really follow up on this durability signal, and it will allow the precision selection of dose or doses that patients and their practitioners really desire. This also confirms to regulatory requirements entering into Phase III.”
5. ABB Ltd (OTC:ABBNY)
Number of Hedge Fund Holders In Q1 2024: N/A
ABB Ltd (OTC:ABBNY) is one of the biggest industrial products companies in the world. It is the first stock from last year’s list that also makes it on our 2024 list of stocks that will change the future. ABB Ltd (OTC:ABBNY)’s shares are up by 36% over the past twelve months, and it makes and sells a variety of robots such as mobile, collaborative, and industrial robots. Its size and scale, as evidenced by $39 billion in total assets and $2.9 billion in cash, means that ABB Ltd (OTC:ABBNY) stands to benefit the most in case the robotics industry picks off. Its considerable presence in the robot industry adds to this competitive moat.
4. Mobileye NV (NYSE:MBLY)
Number of Hedge Fund Holders In Q1 2024: 34
Mobileye NV (NYSE:MBLY) is an autonomous driving company that is an Intel subsidiary. It makes and sells a variety of products for autonomous driving. These provide vehicles with the ability to detect roads in real time and provide drivers with navigation assistance. Mobileye NV (NYSE:MBLY) also enjoys a considerable competitive moat in the assisted driving industry through its SuperVision platform. This is one of the few products in the world that allows for assisted driving at speeds greater than 100 kilometers per hour. While its exclusive focus on assisted driving allows Mobileye NV (NYSE:MBLY) to excel in the industry, it also makes it vulnerable to industry headwinds – such as those generated by greater regulatory scrutiny or tighter regulations.
Mobileye NV (NYSE:MBLY)’s management is aware of its wide moat, as it commented during the Q2 2024 earnings call:
“Ultimately, Mobileye’s long-term growth outlook hinges on our prospects to lead the path of next generation ADAS and solve autonomy while offering a spectrum of product variants appealing to the broadest audience of car makers possible. As a final topic, I’ll highlight some important details of how the EyeQ6 platform represents a leap forward towards these goals and helps position us as the only company in the world that can support all four consumer vehicles categories and Robotaxis as well. As the global OEMs are emerging from a major replanning process, combustion engines versus EV, China versus non-China, buy versus build for autonomy, we are seeing increased clarity on future ADAS and AV segmentation around four distinct categories. Number one, emerging market ADAS as the future growth driver for the 25 million or so vehicles sold today that don’t have any ADAS.
These systems will require lower price for less functionality, yet with high performance, which is where we excel. Number two, developed market ADAS. Recent guidance on future regulations continue to push the envelope on performance, which is a significant positive for us. It’s a key factor in the success of EyeQ6 Lite, which has already been nominated for 50 million units of future business, is involved in many current RFQs and is in — and is progressing towards design wins across all major customers.”
3. Intuitive Surgical, Inc. (NASDAQ:ISRG)
Number of Hedge Fund Holders In Q1 2024: 79
Intuitive Surgical, Inc. (NASDAQ:ISRG) is the world leader when it comes to medical robotics. The firm enjoys a dominant position in an industry, that like the software sector, also benefits from recurring revenue. Since the products that are sold by firms like Intuitive Surgical, Inc. (NASDAQ:ISRG) are quite expensive and are intended to last for years, hospitals and other institutions that buy them often turn to the manufacturer for maintenance and upgrades. This means that Intuitive Surgical, Inc. (NASDAQ:ISRG)’s customer growth also leads to a higher long term revenue base that’s stimulated by recurring revenue. Its DaVinci platform is one of the few of its kind in the world, which allows Intuitive Surgical, Inc. (NASDAQ:ISRG) to enjoy a competitive moat in the form of high barriers to entry. However, given the recent trends in robotics, the firm has to maintain its competitive edge or risk losing out to competitors.
Baron Funds mentioned Intuitive Surgical, Inc. (NASDAQ:ISRG) in its Q2 2024 investor letter. Here is what the firm said:
“Intuitive Surgical, Inc. manufactures the da Vinci Surgical System, a robotic surgical system used for minimally invasive procedures. The stock performed well due to excitement about the company’s new robotic surgical system, the da Vinci 5, which oers enhanced imaging, force feedback and other improvements. We continue to believe Intuitive has durable competitive advantages and will remain the market leader in robotic surgery. We think the company has a long runway for growth as more procedures are performed with the company’s equipment.”
2. Microsoft Corporation (NASDAQ:MSFT)
Number of Hedge Fund Holders In Q1 2024: 293
Microsoft Corporation (NASDAQ:MSFT) is one of the biggest technology companies in the world. It is also one of the key players in the artificial intelligence industry by having partnered up with OpenAI. Microsoft is investing heavily in artificial intelligence, and its capital expenditure sat at a whopping $55.7 billion for the June 2024 fiscal year. Microsoft Corporation (NASDAQ:MSFT) benefits from its considerable enterprise computing market share through the Azure platform, which also provides it with a sizeable market to sell its AI products. At the same time, investor expectations for a return on its AI investments are high, and the firm’s earnings calls are often beset with weak share price movement as it continues to provide weak AI related returns. Microsoft Corporation (NASDAQ:MSFT) is present on both our lists since the media believes that along with AI, it can also play a crucial role in the autonomous driving industry.
Microsoft Corporation (NASDAQ:MSFT)’s latest earnings call was one such event, where the shares only started to recover when management explained:
“For Intelligent Cloud we expect revenue to grow between 18% and 20% in constant currency, or US$28.6 billion to US$28.9 billion. Revenue will continue to be driven by Azure which, as a reminder, can have quarterly variability primarily from our per-user business and in-period revenue recognition depending on the mix of contracts. In Azure, we expect Q1 revenue growth to be 28% to 29% in constant currency. Growth will continue to be driven by our consumption business, inclusive of AI, which is growing faster than total Azure. We expect the consumption trends from Q4 to continue through the first half of the year. This includes both AI demand impacted by capacity constraints and non-AI growth trends similar to June. Growth in our per-user business will continue to moderate.
And in H2, we expect Azure growth to accelerate as our capital investments create an increase in available AI capacity to serve more of the growing demand. In our on-premises server business, we expect revenue to decline in the low single digits as continued hybrid demand will be more than offset by lower transactional purchasing. And in Enterprise and partner services, revenue should decline in the low single digits. In More Personal Computing, we expect revenue to grow between 9% and 12% in constant currency, or US$14.9 billion to US$15.3 billion. Windows OEM revenue growth should be relatively flat, roughly in line with the PC market. In Windows commercial products and cloud services, customer demand for Microsoft 365 and our advanced security solutions should drive revenue growth in the mid-single digits.”
1. NVIDIA Corporation (NASDAQ:NVDA)
Number of Hedge Fund Holders In Q1 2024: 186
NVIDIA Corporation (NASDAQ:NVDA) is the most popular stock in the media when it comes world changing technologies. This is because it can transform the world through artificial intelligence and robotics, according to media reports. NVIDIA Corporation (NASDAQ:NVDA) offers products such as its GR00T model to make AI powered humanoid robots and the Thor system on chip processor for robots. This means that the firm provides an end to end platform that directly targets the robotics industry and is more relevant than say, Rockwell Automation’s products. On the AI front, NVIDIA Corporation (NASDAQ:NVDA)’s GPUs are industry leaders in performance and offer users the key ability to fine tune performance via CUDA. At the same time, the firm’s AI leadership, which has also led to a tight GPU supply and higher prices, could spur big tech into action and develop its own products to relieve some of the pressure. Additionally, any worries about product execution, as evidenced by the recent reports of Blackwel GPU delays, could lead to headwinds for the shares.
NVIDIA Corporation (NASDAQ:NVDA)’s management shared details for Blackwell during the Q1 2025 earnings call:
“At GTC in March, we launched our next-generation AI factory platform, Blackwell. The Blackwell GPU architecture delivers up to 4x faster training and 30x faster inference than the H100 and enables real-time generative AI on trillion-parameter large language models. Blackwell is a giant leap with up to 25x lower TCO and energy consumption than Hopper. The Blackwell platform includes the fifth-generation NVLink with a multi-GPU spine and new InfiniBand and Ethernet switches, the X800 series designed for a trillion parameter scale AI. Blackwell is designed to support data centers universally, from hyperscale to enterprise, training to inference, x86 to Grace CPUs, Ethernet to InfiniBand networking, and air cooling to liquid cooling.
Blackwell will be available in over 100 OEM and ODM systems at launch, more than double the number of Hopper’s launch and representing every major computer maker in the world. This will support fast and broad adoption across the customer types, workloads and data center environments in the first year shipments. Blackwell time-to-market customers include Amazon, Google, Meta, Microsoft, OpenAI, Oracle, Tesla, and xAI. We announced a new software product with the introduction of NVIDIA Inference Microservices or NIM. NIM provides secure and performance-optimized containers powered by NVIDIA CUDA acceleration in network computing and inference software, including Triton Inference Server and TensorRT LLM with industry-standard APIs for a broad range of use cases, including large language models for text, speech, imaging, vision, robotics, genomics and digital biology.”
NVDA, unsurprisingly, leads the list of stocks that can change the world. But our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter timeframe. If you are looking for an AI stock that is more promising than NVDA but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.
READ NEXT: Analyst Sees a New $25 Billion “Opportunity” for NVIDIA and 10 Best of Breed Stocks to Buy For The Third Quarter of 2024 According to Bank of America.
Disclosure: None.
